This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Nau, PhD, RPh, FAPhA Publication Article Drug Topics Journal Drug Topics July/August 2025 Volume 169 Issue 04 Colleges of pharmacy are retooling curricula and faculty skill sets to ensure students are prepared to use the technology of the next decade. Association of American Medical Colleges. Accessed June 1, 2025. News release.
SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. Proactive strategies in oncology care enhance financial sustainability and improve patient outcomes.
Patients were excluded if they had a primary mental health diagnosis of a substance use disorder or no documented Behavioral Health Initial Assessment Form in the electronic medicalrecord. Accessed June 2, 2025. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res.
Postmenopausal women with overweight or obesity who were treated simultaneously with tirzepatide and menopause hormone therapy experienced increased weight loss compared to women treated with tirzepatide alone, according to data presented at ENDO 2025, held July 12 to 15 in San Francisco, California. June 30, 2025. References 1.
The research programme was officially launched at the end of October 2022, and has the aim of building a resource of five million individuals’ information by 2025. It is estimated that this will reach 70% by 2035. Industry interest. This makes it difficult to diagnose MS early. Breakthroughs to come.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content